HurriCaine Topical Anesthetic Liquid Benzocaine 200 mg/g Liquid, 2 g
by Beutlich Pharmaceuticals, LLC · 2 g in 1 APPLICATOR (0283-0569-02)
NDC 00283-0569-02
🏷️ FDA NDC (as labeled)
0283-0569-02
billing pads the labeler segment with a zero
This package
Contains2 g
Pack sizes4 compare ↓
OTC
Discontinued
Non-controlled
⚠ Discontinued by firm
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Benzocaine (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0602-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0605-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0601-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0603-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0604-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0606-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
⚠️
Excluded from the active FDA NDC Directory.
The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory.
Search the FDA NDC Directory ↗
🆔 Identity & classification
FDA NDC (as labeled)
0283-0569-02
Product NDC
0283-0569
11-digit billing NDC
00283056902
UNII
U3RSY48JW5
Application #
M022
SPL Set ID
fee9969d-ad1a-4f44-9741-a0a44c9e1128
Established class (EPC)
Standardized Chemical Allergen
Physiologic effect
Increased Histamine Release; Cell-mediated Immunity
Chemical class
Allergens
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
Discontinued
FDA listing status
Discontinued by firm
Marketing start
1969-05-15
Route
DENTAL, ORAL, PERIODONTAL
Dosage form
LIQUID
Substance
BENZOCAINE
GPI-14
88350010002030
GPI class
Hurricaine
Why two NDCs?
The FDA registers this code as 0283-0569-02 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00283-0569-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Standardized Chemical Allergen class.
Pharmacologic class
Standardized Chemical Allergen
Drug family (ATC)
Local anesthetics, Anesthetics for topical use, Esters of aminobenzoic acid
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerBeutlich Pharmaceuticals, LLC
FDA applicationM022 (OTC MONOGRAPH DRUG)
Labeler code00283
First marketedMay 1969
Product typeHuman Otc Drug
Portfolio16 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
🧪 What is this product?
HurriCaine is a topical liquid containing benzocaine, a local anesthetic, for application to the mouth and gums. This over-the-counter monograph product is typically used to numb minor mouth sores, gum irritation, and other oral discomfort. Benzocaine works by temporarily blocking nerve signals in the area where it is applied, which commonly helps reduce pain during dental procedures or while eating and drinking.
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Benzocaine — tap one for details:
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Benzocaine?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
FlavorCherry
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII B697894SGQ
Polyethylene glycol 400 is a clear, thick liquid made from petroleum-derived polymers. It acts as a solvent and humectant in medicines, helping dissolve active ingredients and retain moisture in the formulation.
-
UNII SB8ZUX40TY
Saccharin sodium is an artificial sweetener made from saccharin salt. It's added to medicines to improve taste, especially in liquid formulations for children or bitter drugs.
2 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesflavor, polyethylene glycol, sodium saccharin
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Benzocaine 20% 200 mg/mL 00121-1077-25 | PAI | 25 pouches | — | — | FDA listed | — |
| HurriCaine Topical Anesthetic Liquid 200 mg/gthis 00283-0569-02 | Beutlich | 2 g | — | — | Discontinued | — |
| HurriCaine Topical Anesthetic Liquid 200 mg/g 00283-1886-17 | Beutlich | 1 g | — | — | FDA listed | — |
| Walgreens Mouth Sore Relief 200 mg/mL 00363-5334-00 | Walgreens | 1 bottle | — | — | FDA listed | — |
| Walgreens Maximum Strength 20 g/100g 00363-5820-58 | Walgreens | 1 bottle | — | — | FDA listed | — |
| Kank-A Mouth Pain 200 mg/mL 10157-9477-01 | Blistex | 9.75 ml | — | — | FDA listed | — |
| Red Cross Oral Pain Relief 200 mg/mL 10742-8902-01 | The | 1 bottle | — | — | FDA listed | — |
| Rite Aid Maximum Strength 20 g/100g 11822-0345-09 | Rite | 1 bottle | — | — | FDA listed | — |
| Rite Aid Professional Strength 20 g/100g 11822-5340-08 | Rite | 1 bottle | — | — | FDA listed | — |
| Topcare Maximum Strength 20 g/100g 36800-0443-48 | Topco | 1 bottle | — | — | FDA listed | — |
| Dental Relief 200 mg/g 42961-0810-03 | Cintas | 10 packets | — | — | FDA listed | — |
| Rexall Maximum Strength 20 g/100mL 55910-0346-79 | Rexall | 1 bottle | — | — | FDA listed | — |
| CVS Pharmacy Maximum Strength 20 g/100g 59779-0743-89 | CVS | 1 bottle | — | — | FDA listed | — |
| Mouth Sore Relief Professional Strength 200 mg/g 59779-0830-38 | CVS | 1 bottle | — | — | FDA listed | — |
| DenTek Instant Pain Relief Maximum Strength 200 mg/mL 60630-0078-01 | DenTek | 1 vial | — | — | FDA listed | — |
| Dental Relief 200 mg/g 68421-8100-03 | Cintas | 10 packets | — | — | FDA listed | — |
| Anesgerm LA MUELA Fast Pain Relief 200 mg/mL 73635-7101-05 | Germa | 1 bottle | — | — | Discontinued | — |
| Oral Anesthetic Liquid 20 g/100g 79481-0118-09 | Meijer, | 1 bottle | — | — | FDA listed | — |
| Anbesol Maximum Strength 200 mg/mL 80070-0230-41 | Foundation | 1 bottle | — | — | FDA listed | — |
| HurriCaine Topical Anesthetic Liquid 200 mg/g 00283-1116-31 | Beutlich | 1 bottle | — | — | Discontinued | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
1969
On the market since
May 1969
📍
2026
Currently FDA-listed
57 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 00283-0569-02 You're viewing this | 2 g in 1 APPLICATOR (0283-0569-02) | 1969-05-15 | Discontinued by firm |
| 00283-0569-17 | 1 g in 1 PACKET (0283-0569-17) | 2020-01-28 | Active |
| 00283-0569-31 | 29.6 g in 1 BOTTLE, PLASTIC (0283-0569-31) | 1969-05-15 | Active |
| 00283-0569-72 | 72 g in 1 APPLICATOR (0283-0569-72) | 1969-05-15 | Discontinued by firm |
Pack size FAQ
What quantity is in NDC 00283-0569-02?
NDC 00283-0569-02 contains 2 g — 2 g in 1 applicator.
What is the difference between NDC 00283-0569-02 and NDC 00283-0569-17?
Both are HurriCaine Topical Anesthetic Liquid Benzocaine 200 mg/g Liquid — the drug itself is identical. NDC 00283-0569-02 is the 2 g package, while NDC 00283-0569-17 is the 1 g package.
What NDC number is used to bill for this package of HurriCaine Topical Anesthetic Liquid Benzocaine 200 mg/g Liquid?
Bill NDC 00283-0569-02 — the 11-digit billing format is 00283056902. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 0283-0569-02, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 00283-0569-02, written without dashes as 00283056902. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 00283-0569-02, the first segment (00283) is the labeler code FDA assigned to Beutlich Pharmaceuticals, LLC; the middle segment (0569) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (02) identifies this exact package size and type. Together they name one specific package of one specific product.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 1 g (00283-0569-17), 29.6 g (00283-0569-31), 72 g (00283-0569-72). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Beutlich Pharmaceuticals, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses for temporary relief of occasional minor irritation and pain associated with: canker sores sore mouth and throat minor injury of the mouth and gums minor dental procedures minor irritation of the mouth and gums caused by dentures or orthodontic appliances
⏱️ Dosage and Administration ▾
Directions Directions do not exceed recommended dosage adults and children 2 years of age and older: apply to the affected area. Allow to remain in place at least 1 minute and then spit out. Use up to 4 times daily or as directed by a dentist or doctor. children under 12 years of age: should be supervised in the use of the product children under 2 years of age: do not use
⚠️ Warnings ▾
Warnings Methemoglobinemia warning: Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops: • pale, gray, or blue colored skin (cyanosis) • headache • rapid heart rate • shortness of breath • dizziness or lightheadedness • fatigue or lack of energy Allergy alert: Do not use if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other "caine" anesthetics.
Sore throat warning: if sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting, consult a doctor promptly. If sore mouth symptoms do not improve in 7 days, or irritation, pain, or redness persists or worsens, see your dentist or doctor promptly.
📦 Storage and Handling ▾
Other information store at 20°-25°C (68°-77°F)
🧪 Active Ingredient ▾
Active ingredient Benzocaine 20%
🧪 Inactive Ingredients ▾
Inactive ingredients flavor, polyethylene glycol, sodium saccharin
🎯 Purpose ▾
Purpose Oral Anesthetic
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.